Status:
UNKNOWN
Study on High-sensitivity Troponin 0h/1h for Rapid Diagnosis of Non-ST-segment Elevation Myocardial Infarction in the Chinese Population
Lead Sponsor:
Beijing Anzhen Hospital
Collaborating Sponsors:
Beckman Coulter, Inc.
Conditions:
Non-ST-segment Elevation Myocardial Infarction
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to establish a high-sensitivity troponin 0h/1h process for the diagnosis of patients suspected of NSTEMI for the Chinese population, obtain the inclusion and exclusion crit...
Eligibility Criteria
Inclusion
- Patients experiencing acute chest pain or angina pectoris symptom within 12 hours before visiting the hospital;
- Or those experiencing acute chest pain or angina pectoris peak within 12 hours before visiting the hospital.
Exclusion
- Patients showing ST-segment elevation during ECG and pregnant women.
Key Trial Info
Start Date :
July 21 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2018
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT03331549
Start Date
July 21 2017
End Date
June 30 2018
Last Update
November 7 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Anzhen Hospital, Capital Medical University
Beijing, China, 100029